Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in pharmaceutical industry.
Sun Pharmaceutical Industries Limited, also popularly known as Sun Pharma, is a listed public company incorporated on 01 March, 1993. It is classified as a public limited company and is located in Vadodara, Gujarat. It's authorized share capital is INR 617.97 cr and the total paid-up capital is INR 239.93 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Pawan Kumar Goenka | 00254502 | 5 years |
| Nodal Officer | Anoop Anjanikumar Deshpande | 02758725 | 5 years |
| Whole-time director | Dilip Shantilal Shanghvi
Shareholder
|
00005588 | 19 years |
| Director | Gautam Bhailal Doshi
Shareholder
|
00004612 | 8 years |
| Deputy Nodal Officer | Meetal Sharad Sampat | 07226509 | 7 years |
| Cfo | Jayashree Satagopan | 06922300 | 1 years |
| Managing Director | Kirti Wardhaman Ganorkar
Shareholder
|
10620142 | 1 years |
| Whole-time director | Vidhi Dilip Shanghvi
Shareholder
|
06497350 | 1 years |
| Whole-time director | Aalok Dilip Shanghvi
Shareholder
|
01951829 | 3 years |
| Director | Rolf Karl Heinz Hoffmann | 10200311 | 3 years |
| Director | Satyavati Berera | 05002709 | 0 years |
| Director | Andreas Eugen Busch | 11699735 | 0 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Bank Limited
No. of Loans: 2
Total Amount : 12.4 cr
RISK CAPITAL AND TECHNOLOGY FINANCE CORPORATION LTD
No. of Loans: 1
Total Amount : 1.5 cr
Gujarat Industrial Investment Corporation Limited
No. of Loans: 1
Total Amount : 1.4 cr
NVFC FINANCE PRIVATE LTD
No. of Loans: 1
Total Amount : 0.8 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Sun Pharmaceutical (Bangladesh) Limited | Bangladesh | - | - |
| Sun Pharmaceutical Industries, Inc. | United States | - | - |
| Sun Farmaceutica do Brasil Ltda | Brazil | - | - |
| Sun Pharma De Mexico S.A. DE C.V. | Mexico | - | - |
| Sun Pharmaceuticals Peru S.A.C. | Peru | - | - |
| Sun Pharma De Venezuela, C.A | Venezuela, Bolivarian Republic Of | - | - |
| Chattem Chemicals Inc. | United States | - | - |
| The Taro Development Corporation | United States | - | - |
| Alkaloida Chemical Company Zrt | Hungary | - | - |
| Sun Pharmaceutical Industries (Australia) Pty Limited | Australia | - | - |
| Aditya Acquisition Company Ltd. | Israel | - | - |
| Sun Pharmaceutical Industries (Europe) B.V. | Netherlands | - | - |
| Sun Pharmaceuticals Germany GmbH | Germany | - | - |
| Sun Laboratories FZE | United Arab Emirates | - | - |
| Sun Pharma Japan Ltd | Japan | - | - |
| Sun Pharma Philippines, Inc. | Philippines | - | - |
| CARACO PHARMACEUTICALS PRIVATE LIMITED | Maharashtra | 2012 | ₹ 1.0 L |
| SUN PHARMA LABORATORIES LIMITED | Gujarat | 1997 | ₹ 40.0 Cr |
| Taro Pharmaceutical Industries Ltd. (Taro) | Israel | - | - |
| Sun Pharma Canada Inc. ( Formely known as Taro Pharmaceuticals Inc.) | Canada | - | - |
| Taro Pharmaceuticals U.S.A., Inc | United States | - | - |
| Taro Pharmaceuticals North America, Inc. | Cayman Islands | - | - |
| Taro International Ltd. | Israel | - | - |
| NEETNAV REAL ESTATE PRIVATE LIMITED | Maharashtra | 2010 | ₹ 41.6 L |
| SOFTDEAL PHARMACEUTICAL PRIVATE LIMITED | Maharashtra | 2006 | ₹ 1.0 L |
| Universal Enterprises Private Limited | Bangladesh | - | - |
| Sun Pharma Switzerland Ltd. | Switzerland | - | - |
| Sun Pharma Holdings | Mauritius | - | - |
| PI Real Estate Ventures, LLC | United States | - | - |
| Sun Pharma East Africa Limited | Kenya | - | - |
| Basics GmbH | Germany | - | - |
| Ranbaxy Pharmaceuticals Ukraine LLC | Ukraine | - | - |
| Sun Pharmaceuticals Morocco LLC | Morocco | - | - |
| Sun Pharmaceutical Industries S.A.C. | Peru | - | - |
| Sun Pharma Holdings UK Limited | United Kingdom | - | - |
| Sun Pharma France | France | - | - |
| Sun Pharma Italia srl | Italy | - | - |
| Ranbaxy Pharmaceuticals (Pty) Ltd | South Africa | - | - |
| Sonke Pharmaceuticals Proprietary Limited | South Africa | - | - |
| Sun Pharma Egypt LLC | Egypt | - | - |
| Rexcel Egypt LLC | Egypt | - | - |
| Sun Pharma UK Limited | United Kingdom | - | - |
| Ranbaxy (Poland) SP. Z O.O. | Poland | - | - |
| Ranbaxy Nigeria Limited | Nigeria | - | - |
| Ranbaxy (Thailand) Co., Ltd. | Thailand | - | - |
| Ohm Laboratories, Inc. | United States | - | - |
| Ranbaxy Signature LLC | United States | - | - |
| Ranbaxy Inc. | United States | - | - |
| AO Ranbaxy | Russian Federation | - | - |
| Sun Pharma Laboratorios,S.L.U. | Spain | - | - |
| Ranbaxy (Malaysia) SDN. BHD. | Malaysia | - | - |
| Ranbaxy Farmaceutica Ltda. | Brazil | - | - |
| Sun Pharma ANZ Pty Ltd | Australia | - | - |
| SC Terapia SA | Romania | - | - |
| Sun Pharma (Netherlands) B.V. | Netherlands | - | - |
| JSC Biosintez | Russian Federation | - | - |
| Sun Pharmaceuticals Holdings USA, Inc | United States | - | - |
| FOUNDATION FOR DISEASE ELIMINATION AND CONTROL OF INDIA | Maharashtra | 2016 | ₹ 1.0 L |
| ZENOTECH LABORATORIES LIMITED | 1989 | ₹ 61.0 Cr | |
| SUN PHARMA DISTRIBUTORS LIMITED | Maharashtra | 2019 | ₹ 15.0 L |
| REALSTONE INFRA LIMITED | Maharashtra | 2020 | ₹ 25.0 L |
| Sun Pharmaceuticals (EZ) Limited | Bangladesh | - | - |
| Sun Pharma (Shanghai) Co.,Ltd | China | - | - |
| Alchemee, LLC | United States | - | - |
| Proactiv YK | United States | - | - |
| The Proactiv Company KK | Japan | - | - |
| The Proactiv Company Holdings, Inc. (Formerly known as Galderma Holdings, Inc.) | United States | - | - |
| Alchemee Skincare Corporation (Formerly known as The Proactiv Company Corporation) | United States | - | - |
| Concert Pharma Ireland Limited | Ireland | - | - |
| Taro Pharma Corporation, Inc. | United States | - | - |
| VIVALDIS HEALTH AND FOODS PRIVATE LIMITED | Maharashtra | 2014 | ₹ 42.5 L |
| Sun Pharma Middle East FZE LLC | United Arab Emirates | - | - |
| Sun Pharma Luxembourg S.A( Formely known as Valstar S.A.) | Luxembourg | - | - |
| Sun Pharmaceuticals North Africa SA (Formely Known as Kemipharm) | Morocco | - | - |
| Sun Pharma Community Healthcare Society | India | - | - |
| Ranbaxy South Africa (Pty) Ltd | South Africa | - | - |
| Sun Pharma Science Foundation | India | - | - |
| Sun Pharma (Hainan) Company Limited | China | - | - |
| Checkpoint Therapeutics, Inc. | United States | - | - |
Read more
The incorporation date of SUN PHARMACEUTICAL INDUSTRIES LIMITED is 01 March, 1993
The authorized share capital of SUN PHARMACEUTICAL INDUSTRIES LIMITED is INR ₹ 618.0 Cr.
The paid-up capital of SUN PHARMACEUTICAL INDUSTRIES LIMITED is INR ₹ 239.9 Cr.
The registered address of SUN PHARMACEUTICAL INDUSTRIES LIMITED is SPARC, TANDALJA VADODARA Gujarat - 390012
The CIN number of SUN PHARMACEUTICAL INDUSTRIES LIMITED is L24230GJ1993PLC019050.